Optimus HealthCare Services Acquires PainScript

Optimus Healthcare Services, Inc., acquired AdhereRx, d/b/a PainScript, a SaaS-based, telehealth/chronic care compliance platform company. The transaction is valued at $4.5 million. PainScript’s chief executive officer, Dan Cohen will continue in that role and will become president of Optimus.

PainScript’s medical treatment compliance platform is focused on creating a personalized pathway to support chronic care management interventions for people with opioid and other addiction disorders. The platform uses technology based clinically validated protocols. The platform is currently in a beta-phase test; the commercial launch is anticipated during the second half of 2021. The initial focus will be on people with addiction disorder who are under psychiatric care.  PainScript anticipates expanding the platform into other chronic care treatment areas including pain management.

The platform uses daily contact between scheduled therapy treatments as the evidence demonstrates greater adherence to clinical protocols that, in turn, leads to an improved health benefit. The PainScript platform is designed with a HIPAA compliant, “concierge medicine” approach, allowing for real-time physician-consumer interactions, remote monitoring and communication, appointment scheduling, and an early warning of treatment complications.

“The agreement we reached today to acquire PainScript is another milestone in the Optimus strategy to bring best-in-class health technologies in-house as portfolio companies,” said Kenneth Orr, Executive Chair of Optimus. “We believe the PainScript platform to provide a more effective chronic care compliance treatment for Substance Use Disorder (SUD) patients has the potential to be transformational.”

“In addition, the PainScript telehealth platform and its ability to adapt its platform to other chronic care patients needs in areas such as pain management, bariatrics and similar disease treatments is a unique approach that will lead to better patient care and better health outcomes,” added Mr. Orr. “PainScript will be the first company to join our newly formed telehealth and medication compliance division, to be known as Telehealth Adherence and Compliance Technologies or TACT.”

Optimus focuses on acquiring controlling interests in health care-related businesses. It has filed for a name change to Optimus Healthcare Services, Inc. which is pending regulatory approval. The company was formed in 2020, and is controlled by KORR Acquisitions Group, Inc. On December 29, 2020, Between Dandelions Inc. merged with Optimus, and is changing its name to Optimus Healthcare Services Inc.

This was reported by Optimus Healthcare Services, Inc. on March 25, 2021.

Contact information: Marc Wiener, Chief Executive Officer, Optimus HealthCare Services, Inc., 516-669-6555; Email: mwiener@researchcra.com; Website: https://www.clinicalresearchalliance.org/

Contact information: Dan Cohen, Chief Executive Officer, PainScript Corporation, 5920 Hubbard Drive, Rockville, Maryland 20852; 202-329-1825; Email: dlc@painscript.com; Website: https://painscript.com/

‍